LEROCHOL DIRECT Trademark

Trademark Overview


On Tuesday, June 9, 2026, a trademark application was filed for LEROCHOL DIRECT with the United States Patent and Trademark Office. The USPTO has given the LEROCHOL DIRECT trademark a serial number of 99874431. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 9, 2026. This trademark is owned by LIB Therapeutics, Inc.. The LEROCHOL DIRECT trademark is filed in the Advertising, Business and Retail Services category with the following description:

business administration of a cash-pay program offering discounted prices for prescription drugs sold directly to patients not using insurance
lerochol direct

General Information


Serial Number99874431
Word MarkLEROCHOL DIRECT
Filing DateTuesday, June 9, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, June 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesbusiness administration of a cash-pay program offering discounted prices for prescription drugs sold directly to patients not using insurance

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, June 9, 2026
Primary Code035
First Use Anywhere DateMonday, May 11, 2026
First Use In Commerce DateMonday, May 11, 2026

Trademark Owner History


Party NameLIB Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45227
US

Trademark Events


Event DateEvent Description
Tuesday, June 9, 2026NEW APPLICATION ENTERED
Tuesday, June 9, 2026APPLICATION FILING RECEIPT MAILED